Neoadjuvant Chemotherapy With Doxorubicin and Cisplatin in Malignant Fibrous Histiocytoma of Bone: A European Osteosarcoma Intergroup Study
- 1 October 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (10) , 3260-3269
- https://doi.org/10.1200/jco.1999.17.10.3260
Abstract
PURPOSE: Studies involving small case series have suggested that malignant fibrous histiocytoma of bone (MFH-B) is a chemosensitive tumor and that chemotherapy may improve survival. In this study, ...Keywords
This publication has 28 references indexed in Scilit:
- How is the mutational status for tumor suppressors p53 and p16INK4A in MFH of the bone?Cancer Letters, 1998
- Malignant fibrous histiocytoma of boneCancer, 1997
- MALIGNANT FIBROUS HISTIOCYTOMA OF BONE: THE EXPERIENCE OF THE NEW SOUTH WALES BONE TUMOUR REGISTRYAnz Journal of Surgery, 1993
- Pleomorphic Malignant Fibrous HistiocytomaThe American Journal of Surgical Pathology, 1992
- Postradiation Malignant Fibrous Histiocytoma of BoneThe American Journal of Surgical Pathology, 1986
- The pathology of malignant fibrous histiocytoma of boneThe American Journal of Surgical Pathology, 1985
- Malignant fibrous histiocytoma of bone the experience at the Rizzoli Institute: Report of 90 casesCancer, 1984
- Malignant (fibrous) histiocytoma of bone-fact or fancy?Cancer, 1977
- Primary malignant fibrous histiocytoma of boneCancer, 1975
- Intra- and Extraosseous Malignant Histiocytoma (Malignant Fibrous Xanthoma)Radiology, 1972